Back to search

Article

Pan-cancer analysis to provide a reliable basis for the clinical use of TIM-3 immunosuppressants

2023-01-11

Abstract excerpt

<h4>Background: </h4> TIM-3 belongs to the immunoglobulin superfamily and is currently one of the most valuable immunosuppressants. HAVCR2 is the gene that codes for TIM-3, and its expression has been linked to the clinical efficacy of TIM-3 immunosuppressants. The study aims to provide potential guidance for the use of TIM-3 immunosuppressants in pan-cancer. Methods Data related to HAVCR2 in pan-cancer was obtai...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
73207612-d14a-59bf-a96d-57d9e7c37096
DOI
10.21203/rs.3.rs-2446588/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pan-cancer analysis to provide a reliable basis for the clinical use of TIM-3 immunosuppressantsDOI 10.21203/rs.3.rs-2446588/v1
Select a neighboring publication to make it the new centre.